CompletedNot Applicable

Salivary and Serum Levels of Chemerin and MMP-9 in Oral Premalignant and Malignant Lesions

45 participantsStarted 2014-02

Plain-language summary

45 individuals were subdivided into 3 groups, 15 patients with oral premalignant lesions, 15 patients with oral malignant lesions and 15 control individuals. Levels of chemerin and MMP-9 were evaluated in serum and saliva of these subjects utilizing the ELISA technique.

Who can participate

Age range40 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients with oral premalignant lesions. * patients with oral malignant lesions. Exclusion Criteria: * any systemic disease other than oral premalignant or malignant lesions. smokers. pregnant females. periodontal diseases.

What they're measuring

salivary levels of chemerin in patients with oral premalignant and malignant lesions.

Timeframe: 1 day

Trial details

NCT IDNCT02323672

SponsorCairo University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2014-09

View on ClinicalTrials.gov More Precancerous Conditions trials